Lectenz Bio in News and Media

June 9, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Scientist.com, a U.S. life science distributor. This agreement will allow...

May 4, 2022 0 0

Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!

February 28, 2022 0 0

Lectenz Bio was proud to be a sponsor of the 2022 Rare Disease Day Symposium & CDG/NGLY1 Family Conference! It’s always exciting to see...

February 4, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Krishgen Biosystems, an Indian life science distributor. This agreement will allow...

December 6, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with Advion Interchim, a French life science distributor. This agreement will allow...

November 16, 2021 0 0

Lectenz Bio attended and sponsored the Society for Glycobiology 2021 Annual Meeting in San Diego. Dr. Shaza Abnouf and Christian Gerner-Smidt...

August 25, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with Hölzel Diagnostika, a life sciences distributor. This agreement will allow Hölzel...

January 25, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with 2B Scientific, a life sciences distributor. This agreement will allow 2B Scientific...

January 15, 2021 0 0

We are excited to announce Dr. Sean Wu as our new Vice President of Research and Development. A veteran team member, Dr. Wu has worked at Lectenz...

December 7, 2020 0 0

Lectenz Bio has recently signed a distribution agreement with Funakoshi Co., Ltd., a Japanese life science distributor. This agreement will allow...

March 16, 2020 0 0

We’d like to take a brief moment to update you on our company plans as the COVID-19 situation progresses. At Lectenz Bio, our employees’ safety is...

January 23, 2020 0 0

The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop heparan sulfate...